MEDIUM confidence: 100% data completeness, but the composite (43) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-12.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $219M— | $284M+29.6% | $144M-49.2% | $203M+40.8% | $327M+61.2% |
| EPS (dil.) | $1.53— | $1.03-32.7% | $-3.63-452.4% | $-4.05n/m | $-1.72n/m |
| Free Cash Flow | $25M— | $4M-83.8% | -$4M-202.2% | -$13Mn/m | $35Mn/m |
| Gross Margin | 63.7% | 64.5%+0.8pp | 57.0%-7.5pp | 51.6%-5.5pp | 53.6%+2.0pp |
| Operating Margin | 15.0% | 5.7%-9.3pp | -74.4%-80.1pp | -56.9%+17.6pp | -18.5%+38.4pp |
| Net Margin | 14.8% | 8.2%-6.6pp | -55.9%-64.1pp | -46.2%+9.8pp | -13.1%+33.0pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Avg target $880 (last qtr, 3 analysts) → $880 (last mo, 3) (+0.0%).
Buy-rated share 90% → 100% over ~3 months (+10pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $1.95 | $2.34 | +20.0% |
| May 2026 | $1.16 | $1.44 | +24.1% |
| Feb 2026 | $1.20 | $1.53 | +27.5% |
| Nov 2025 | $0.71 | $0.87 | +22.5% |
| Aug 2025 | $0.29 | $0.47 | +62.1% |
| May 2025 | $0.11 | $0.26 | +136.4% |
| Feb 2025 | $0.42 | $0.48 | +14.3% |
| Nov 2024 | $0.26 | $0.40 | +53.5% |
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 71.9%/yr (revenue basis).
Base free cash flow $6M (avg FY2023–FY2025; latest year $35M) · equity value $18.5B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Net insider -$374.0M over 180 days (0 open-market buys, 31 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
The QScore of 43 for SITM indicates a neutral outlook, with the stock's high growth and momentum scores offset by poor value and risk metrics. SITM scores high on growth, driven by revenue growth of 61.2% and EPS growth of 57.5%, and exhibits strong momentum with a 12-month return of 221.5%. However, it trades at a significant premium, with a P/E of 1322.2, and has a high beta of 2.9, contributing to its low value and risk scores. The short-term score is notably higher than the long-term score, at 49 versus 38.